Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Thermo Fisher Secures Phadia

Facebook Twitter LinkedIn Email Comments
Thermo Fisher Scientific Inc. of Waltham, Mass., has acquired Phadia of Uppsala, Sweden, a provider of blood tests for the clinical diagnosis and monitoring of allergies and autoimmune diseases. Phadia now is part of Thermo Fisher’s Specialty Diagnostics business. The company is expected to contribute $0.07 to Thermo Fisher’s 2011 full-year adjusted earnings per share, an increase of $0.01 over the original estimate. In addition, it is expected to add $190 million to the US company’s 2011 revenue results, about a 12% growth in revenue over 2010.

Photonics Spectra
Nov 2011
AmericasBiophotonicsblood test monitoringblood tests for clinical diagnosisBusinessearnings per shareEPSEuropelight speedMassachusettsPhadiaSwedentesting for allergies and autoimmune diseasesThermo FisherThermo Fisher ScientificThermo Fisher Specialty Diagnostics

Comments
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2020 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to Photonics Spectra magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.